secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeMD, Inc. (LFMD)
CIK:        0000948320
Form:       8-K
Filed at:   2022-01-19T23:59:59+00:00
Accession:  0001493152-22-001552
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeMD reports FY2021 preliminary revenue of $92.9M, +149% YoY; FY2022 guidance $142-148M
--------------------------------------------------------------------------------

- Preliminary Q4 2021 revenue $27.4M; FY2021 revenue $92.9M (149% YoY growth).
- FY2022 revenue guidance $142-148M; Adj. EBITDA loss guidance ($14M)-($20M).
- Q1 2022 revenue guidance $30-32M; Adj. EBITDA loss ($6.5M)-($7.5M).
- Reaffirms Adj. EBITDA profitability target by Q4 2022.
- Company highlights acquisition of Cleared and launch of LifeMD Virtual Primary Care Platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/948320/000149315222001552/0001493152-22-001552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/948320/000149315222001552/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-001552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer